Interventions for treating painful sickle cell crisis during pregnancy

Cochrane Database of Systematic Reviews

Volumn , Issue 1, 2009, Pages

  Martí Carvajal, Arturo J ^a,c   Peña Martí, Guiomar E ^b   Comunián Carrasco, Gabriella ^b   Martí Peña, Arturo J ^c  

^a Iberoamerican Cochrane Network   (Venezuela)

^b UNIVERSIDAD DE CARABOBO   (Venezuela)

^c NONE   (Venezuela)

Author keywords

Anemia, sickle cell *therapy ; Female; Humans; Pain *therapy ; Pregnancy; Pregnancy complications, hematologic *therapy

Indexed keywords

METFORMIN; MULTIVITAMIN; PLACEBO; SIBUTRAMINE; TETRAHYDROLIPSTATIN; ANTIBIOTIC AGENT; ANTIFUNGAL AGENT; GLYCEROL; LANOLIN; PEPPERMINT OIL; PETROLATUM; POLYETHYLENE; SILICONE;

ABDOMINAL DISCOMFORT; ABDOMINAL PAIN; ANXIETY DISORDER; BEHAVIOR THERAPY; BLOOD PRESSURE; BONE DENSITY; CHOLELITHIASIS; CINAHL; CLINICAL TRIAL; COCHRANE LIBRARY; DATA BASE; DEFECATION; DEPRESSION; DIARRHEA; DIASTOLIC BLOOD PRESSURE; DIZZINESS; DRUG DOSE REDUCTION; DRUG WITHDRAWAL; ECCHYMOSIS; ECG ABNORMALITY; EMBASE; FAMILY; FOLLOW UP; GALLSTONE; GASTROINTESTINAL SYMPTOM; HEADACHE; HEART VENTRICLE EXTRASYSTOLE; HUMAN; HYDRONEPHROSIS; HYPERTENSION; INTERVENTION STUDY; LACTIC ACIDOSIS; LIFESTYLE MODIFICATION; MEDLINE; MIGRAINE; MUSCLE CRAMP; NAUSEA; NAUSEA AND VOMITING; NUTRITIONAL ASSESSMENT; OBESITY; OUTCOME ASSESSMENT; PHYSICAL ACTIVITY; PSYCINFO; PULSE RATE; RASH; REVIEW; RHINOPHARYNGITIS; SIDE EFFECT; SITTING; SYSTEMATIC REVIEW; TACHYCARDIA; THERAPY EFFECT; TREATMENT OUTCOME; UPPER RESPIRATORY TRACT INFECTION; VITAMIN BLOOD LEVEL; VOMITING; WEIGHT CONTROL; WEIGHT REDUCTION; XEROSTOMIA; FEMALE; PAIN; PREGNANCY; PREGNANCY COMPLICATION; SICKLE CELL ANEMIA; BREAST FEEDING; HYDROGEL; MASTALGIA; MASTITIS; PATIENT SATISFACTION; TREATMENT INDICATION;

ANEMIA, SICKLE CELL; FEMALE; HUMANS; PAIN; PREGNANCY; PREGNANCY COMPLICATIONS, HEMATOLOGIC;

EID: 70249146130     PISSN: 1469493X     EISSN: None     Source Type: Journal    
DOI: 10.1002/14651858.CD006786.pub2     Document Type: Review

References (44)

1. ACOG Practice Bulletin. Hemoglobinopathies in pregnancy. Obstetrics & Gynecology 2007;109:229-237
2. Adam S. Caring for the pregnant woman with sickle cell crisis. Professional Care of Mother and Child 1996;6:34-36
3. Babela JR, Nzingoula S, Senga P. Sickle-cell crisis in the child and teenager in Brazzaville, Congo. A retrospective study of 587 cases. Bulletin de la Société de Pathologie Exotique 2005;98:365-370
4. Ballas SK, Lusardi M. Hospital readmission for adult acute sickle cell painful episodes: frequency, etiology, and prognostic significance. American Journal of Hematology 2005;79:17-25.
5. Bunn HF. Pathogenesis and treatment of sickle cell disease. New England Journal of Medicine 1997;337:762-769
6. Chamberlain G. ABC of antenatal care. Medical problems in pregnancy - II. BMJ 1991;302(6788):1327-1330
7. Diallo D, Tchernia G. Sickle cell disease in Africa. Current Opinion in Hematology 2002;9:111-116
8. Dunlop RJ, Bennett KCLB. Pain management for sickle cell disease. Cochrane Database of Systematic Reviews 2006, Issue 2. [Art. No.: CD003350. DOI: 10.1002/14651858.CD003350.pub2]
9. Finkel JL. Assessment of opioid analgesia in sickle cell. www.controlled-trials.com/ (accessed 5 December 2007).
10. Hebbel RP, Osarogiagbon R, Kaul D. The endothelial biology of sickle cell disease: inflammation and a chronic vasculopathy. Microcirculation 2004;11:129-151
11. Higgins JPT, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. BMJ 2003;327(7414):557-560
12. Higgins JPT, Green S, editors. Cochrane Handbook for Systematic Reviews of Interventions 4.2.5 [updated May 2005]. In: The Cochrane Library, Issue 3, 2005. Chichester, UK: John Wiley & Sons, Ltd.
13. International Conference on Harmonisation Expert Working Group. International conference on harmonisation of technical requirements for registration of pharmaceuticals for human use. ICH harmonised tripartite guideline. Guideline for good clinical practice. www.ich.org/cache/compo/276- 254-1.html (accessed 12 January 2007).
14. Kato GJ, Gladwin MT, Steinberg MH. Deconstructing sickle cell disease: reappraisal of the role of hemolysis in the development of clinical subphenotypes. Blood Reviews 2007;21:37-47. [MEDLINE: 17084951]
15. Kobak AJ, Stein PJ, Daro AF. Sickle cell anemia in pregnancy: a review of the literature and report of six cases. American Journal of Obstetrics and Gynecology 1941;41:811-823
16. Kondylis-deBlois K, Feingold M. Sickle cell disease. Primary Care Update Obstetrics and Gynecology 1998;5:28-31.
17. Kopecky EA, Ryan ML, Barrett JF, Seaward PG, Ryan G, Koren G, et al.Fetal response to maternally administered morphine. American Journal Obstetrics and Gynecology 2000;183:424-430
18. Leborgne-Samuel Y, Kadhel P, Ryan C, Vendittelli F. Sickle cell disease and pregnancy. La Revue du Praticien 2004;54(14):1578-1582
19. Macias C. Steroid treatment for sickle cell pain crisis. www.controlled-trials.com/ (accessed 5 December 2007).
20. Mack AK, Kato GJ. Sickle cell disease and nitric oxide: a paradigm shift?. International Journal of Biochemistry & Cell Biology 2006;38: 1237-1242 [MEDLINE: 16517208]
21. Martin JN Jr, Martin RW, Morrison JC. Acute management of sickle cell crisis in pregnancy. Clinics in Perinatology 1986;13:853-868
22. National Institutes of Health Clinical Center. Nitric oxide inhalation to treat sickle cell pain crises. http: //clinicaltrials.gov/ct2/show/NCT00094887 (accessed 5 December 2007).
23. Odum CU, Anorlu RI, Dim SI, Oyekan TO. Pregnancy outcome in HbSS-sickle cell disease in Lagos, Nigeria. West African Journal of Medicine 2002;21:19-23.
24. Oteng-Ntim E, Cottee C, Bewley S, Anionwu EN. Sickle cell disease in pregnancy. Current Obstetrics and Gynaecology 2006;16:353-360
25. Pauling L, Itano HA, Singer SJ, Wells IC. Sickle cell anemia, a molecular disease. Science 1949;110:543-546
26. Powars DR, Sandhu M, Niland-Weiss J, Johnson C, Bruce S, Manning PR. Pregnancy in sickle cell disease. Obstetrics & Gynecology 1986;67(2):217-228
27. Quinn CT. Ketorolac versus ibuprofen to treat painful episodes of sickle cell disease. www.controlled-trials.com/ (accessed 5 December 2007).
28. Rajab KE, Issa AA, Mohammed AM, Ajami AA. Sickle cell disease and pregnancy in Bahrain. International Journal of Gynecology & Obstetrics 2006;93:171-175
29. Saunthararajah Y, Vichinsky EP, Embury SH. Sickle cell disease. In: Hoffman R editor(s). Hematology: basic principles and practice. Edinburgh: Churchill Livingstone, 2004.
30. Serjeant GR. Sickle cell disease. Lancet 1997;350:725-730
31. Serjeant GR. The emerging understanding of sickle cell disease. British Journal of Haematology 2001;112:3-18.
32. Serjeant GR, Loy LL, Crowther M, Hambleton IR, ThameM. Outcome of pregnancy in homozygous sickle cell disease. Obstetrics & Gynecology 2004;103:1278-1285
33. Serjeant GR, Hambleton I, Thame M. Fecundity and pregnancy outcome in a cohort with sickle cell-haemoglobin C disease followed from birth. BJOG: an international journal of obstetrics and gynaecology 2005;112:1308-1314
34. Shord SS. Codeine in sickle cell disease. http://www.clinicaltrials.gov/ ct2/show/NCT00174538 (accessed 5 December 2007).
35. Steinberg MH. Pathophysiologically based drug treatment of sickle cell disease. Trends in Pharmacological Sciences 2006;27:204-210
36. Stuart MJ, Nagel RL. Sickle-cell disease. Lancet 2004;364:1343-1360
37. Sun PM, Wilburn W, Raynor BD, Jamieson D. Sickle cell disease in pregnancy: twenty years of experience at Grady Memorial Hospital, Atlanta, Georgia. American Journal of Obstetrics and Gynecology 2001; 184:1127-1130
38. Thame M, Lewis J, Trotman H, Hambleton I, Serjeant G. Themechanisms of low birth weight in infants of mothers with homozygous sickle cell disease. Pediatrics 2007;120(3):e686-e693.
39. van Beers EJ, van Tuijn CF, Nieuwkerk PT, Friederich PW, Vranken JH, Biemond BJ. Patient-controlled analgesia versus continuous infusion of morphine during vaso-occlusive crisis in sickle cell disease, a randomized controlled trial. American Journal of Hematology 2007; 82(11):955-960
40. Villers MS, Jamison MG, De Castro LM, James AH. Morbidity associated with sickle cell disease in pregnancy. American Journal of Obstetrics and Gynecology 2008;199(2):125.e1-125.e5. [MEDLINE: 18533123]
41. Weatherall D, Akinyanju O, Fucharoen S, Olivieri N, Musgrove P. Inherited disorders of hemoglobin. Disease control priorities in developing countries. 2nd Edition. Washington (DC): The World Bank and Oxford University Press, 2006:663-680
42. World Health Organization. Sickle-cell anaemia. http://www.who.int/gb/ ebwha/pdf-files/WHA59/A59-R20-en.pdf 2006.
43. Wood KC, Hsu LL, Gladwin MT. Sickle cell disease vasculopathy: a state of nitric oxide resistance. Free Radical Biology &Medicine 2008; 44:1506-1528 [MEDLINE: 18261470]
44. Zavala D, Martí A, Peña-Martí G, Comunián G. Sheet to enter data for performing a Cochrane review. Universidad de Carabobo, Valencia, Venezuela 2006.